Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-PRP for Endometrial Pathologies
NCT05095597Phase 2Completed
- Sponsor
- Fundación IVI
- Start
- Apr 2022
- Primary completion
- Jan 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord platelet-rich plasma in Asherman syndrome (IUA), endometrial atrophy, thin endometrium, sponsored by Fundación IVI. Started Apr 2022; status: completed.
02
Drugs
human umbilical cord platelet-rich plasma
03
Conditions
Asherman syndrome (IUA)endometrial atrophythin endometrium
Beyond the preview
Go deeper on NCT05095597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095597.